Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $25.6400 (4.91%) ($24.4500 - $25.8200) on Mon. Jun. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.18% (three month average) | RSI | 58 | Latest Price | $25.6400(4.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2.1% a day on average for past five trading days. | Weekly Trend | HALO advances 1.1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(51%) IBB(50%) IWM(48%) IWC(45%) ARKG(43%) | Factors Impacting HALO price | HALO will decline at least -1.59% in a week (0% probabilities). VIXM(-32%) UUP(-16%) VXX(-14%) TLT(-3%) IYT(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.59% (StdDev 3.18%) | Hourly BBV | 0 () | Intraday Trend | 3.4% | | | |
|
5 Day Moving Average | $24.12(6.3%) | 10 Day Moving Average | $23.71(8.14%) | 20 Day Moving Average | $23.78(7.82%) | To recent high | 0% | To recent low | 57.8% | Market Cap | $3.504b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |